{"name":"HealthCap","permalink":"healthcap","crunchbase_url":"http://www.crunchbase.com/financial-organization/healthcap","homepage_url":"http://www.healthcap.se","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"46-8-442-58-50","description":"Live-sciences focused fund-of-funds","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jun 24 15:36:31 UTC 2009","updated_at":"Mon Jul 27 22:28:42 UTC 2009","overview":"<p>HealthCap is a family of multi stage venture capital funds, investing globally in life sciences, with the Odlander Fredrikson Group as their exclusive investments advisor. With committed capital exceeding â‚¬ 800 million, HealthCap is one of the largest specialized provider of venture capital within life sciences Europe.</p>","image":{"available_sizes":[[[150,46],"assets/images/resized/0005/4096/54096v1-max-150x150.png"],[[250,77],"assets/images/resized/0005/4096/54096v1-max-250x250.png"],[[450,139],"assets/images/resized/0005/4096/54096v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"StrandvÃ¤gen 5B","address2":"SE-114 51 Stockholm","zip_code":"","city":"","state_code":null,"country_code":"SWE","latitude":56.9010745,"longitude":12.501033}],"relationships":[],"investments":[{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/lumavita-ag-series-a-55m/","source_description":"Lumavita, AG: Series A $5.5M","raised_amount":5500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":24,"company":{"name":"Lumavita","permalink":"lumavita","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0531/50531v1-max-150x150.png"],[[182,51],"assets/images/resized/0005/0531/50531v1-max-250x250.png"],[[182,51],"assets/images/resized/0005/0531/50531v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.chemocentryx.com/news/2004/pr20040617.pdf","source_description":"ChemoCentryx Raises $33 Million in Private Financing","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2004,"funded_month":6,"funded_day":17,"company":{"name":"ChemoCentryx","permalink":"chemocentryx","image":{"available_sizes":[[[127,77],"assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],[[127,77],"assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/benechill-inc-series-c-135m/","source_description":"BeneChill, Inc.: Series C $13.5M","raised_amount":13500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":9,"funded_day":15,"company":{"name":"BeneChill","permalink":"benechill","image":{"available_sizes":[[[150,21],"assets/images/resized/0006/0164/60164v1-max-150x150.jpg"],[[250,35],"assets/images/resized/0006/0164/60164v1-max-250x250.jpg"],[[450,63],"assets/images/resized/0006/0164/60164v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/pulmonx-inc-series-c-32m/","source_description":"Pulmonx, Inc.: Series C $32M","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":8,"company":{"name":"Pulmonx","permalink":"pulmonx","image":{"available_sizes":[[[150,74],"assets/images/resized/0005/9579/59579v1-max-150x150.png"],[[165,82],"assets/images/resized/0005/9579/59579v1-max-250x250.png"],[[165,82],"assets/images/resized/0005/9579/59579v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.tengion.com/news/press/20071015.cfm","source_description":"Tengion Closes $33 Million in Series C Funding Deerfield Partners Joins Investor Group as Company Advances Novel Regenerative Medicine Products","raised_amount":33000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":15,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.oxthera.com/pr.php?no=2","source_description":"OxThera Raises SEK 150 Million in New Round of Financing","raised_amount":150000000,"raised_currency_code":"SEK","funded_year":2007,"funded_month":6,"funded_day":29,"company":{"name":"OxThera","permalink":"oxthera","image":{"available_sizes":[[[127,45],"assets/images/resized/0008/0099/80099v1-max-150x150.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-250x250.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/immune-targeting-systems-ltd-series-a-132/","source_description":"Immune Targeting Systems, Ltd.: Series A $13.2","raised_amount":13200000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Immune Targeting Systems","permalink":"immune-targeting-systems","image":{"available_sizes":[[[150,11],"assets/images/resized/0008/0812/80812v1-max-150x150.jpg"],[[250,19],"assets/images/resized/0008/0812/80812v1-max-250x250.jpg"],[[450,35],"assets/images/resized/0008/0812/80812v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.tengion.com/news/press/20060623.cfm","source_description":"Tengion Inc. Completes $50 Million Series \"B\" Round Financing led by Bain Capital and Quaker BioVentures will support neo-bladder clinical trials, manufacturing capacity and pipeline development","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":23,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://bulletin.sciencebusiness.net/sb/login.php?page=/ebulletins/showissue.php3?page=/548/art/6762","source_description":"Lund's BoneSupport raises SEK135M for bone substitute","raised_amount":135000000,"raised_currency_code":"SEK","funded_year":2006,"funded_month":11,"funded_day":24,"company":{"name":"BONESUPPORT","permalink":"bonesupport","image":{"available_sizes":[[[150,54],"assets/images/resized/0008/4551/84551v1-max-150x150.jpg"],[[185,67],"assets/images/resized/0008/4551/84551v1-max-250x250.jpg"],[[185,67],"assets/images/resized/0008/4551/84551v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"","source_description":"Cap Funding Report","raised_amount":13960000,"raised_currency_code":"USD","funded_year":2006,"funded_month":9,"funded_day":26,"company":{"name":"Resistentia Pharmaceuticals","permalink":"resistentia-pharmaceuticals","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/oncos-therapeutics-ltd-series-c-55m/","source_description":"Oncos Therapeutics, Ltd.: Series C $5.5M","raised_amount":5500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":4,"funded_day":30,"company":{"name":"Oncos Therapeutics","permalink":"oncos-therapeutics","image":{"available_sizes":[[[150,86],"assets/images/resized/0008/6146/86146v1-max-150x150.png"],[[250,144],"assets/images/resized/0008/6146/86146v1-max-250x250.png"],[[260,150],"assets/images/resized/0008/6146/86146v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss","source_description":"FerroKin rounds up $12M for iron overload treatment  Read more: FerroKin rounds up $12M for iron overload treatment - FierceBiotech http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss#ixz","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":18,"company":{"name":"FerroKin Biosciences","permalink":"ferrokin-biosciences","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.fiveprime.com/index.php?option=com_content&task=view&id=27&Itemid=71","source_description":"Five Prime Therapeutics, Inc. Raises $45MM in Private Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":2,"funded_day":8,"company":{"name":"Five Prime Therapeutics","permalink":"five-prime-therapeutics","image":{"available_sizes":[[[150,55],"assets/images/resized/0004/5633/45633v1-max-150x150.png"],[[185,68],"assets/images/resized/0004/5633/45633v1-max-250x250.png"],[[185,68],"assets/images/resized/0004/5633/45633v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://phx.corporate-ir.net/phoenix.zhtml?c=218965&p=irol-newsArticle&ID=1431504&highlight=","source_description":"Tengion Inc. Completes $39 Million Series \"A\" Round Financing Will Advance Development of Regenerative Medicine Products","raised_amount":39000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":8,"funded_day":3,"company":{"name":"Tengion","permalink":"tengion","image":{"available_sizes":[[[150,31],"assets/images/resized/0007/9906/79906v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0007/9906/79906v1-max-250x250.jpg"],[[289,61],"assets/images/resized/0007/9906/79906v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ptct.client.shareholder.com/releasedetail.cfm?ReleaseID=197021","source_description":"PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING","raised_amount":26600000,"raised_currency_code":"USD","funded_year":2005,"funded_month":11,"funded_day":10,"company":{"name":"PTC Therapeutics","permalink":"ptc-therapeutics","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],[[208,97],"assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.oxthera.com/pr.php?no=3","source_description":"External financing of SEK 165 million secured for Q-Med's oxalate project","raised_amount":165000000,"raised_currency_code":"SEK","funded_year":2005,"funded_month":7,"funded_day":11,"company":{"name":"OxThera","permalink":"oxthera","image":{"available_sizes":[[[127,45],"assets/images/resized/0008/0099/80099v1-max-150x150.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-250x250.jpg"],[[127,45],"assets/images/resized/0008/0099/80099v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.cerenis.com/media-detail.asp?id=253","source_description":"Cerenis Therapeutics raises EUR 40 million in series C financing","raised_amount":40000000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":7,"funded_day":26,"company":{"name":"Cerenis Therapeutics","permalink":"cerenis-therapeutics","image":{"available_sizes":[[[150,64],"assets/images/resized/0010/6866/106866v1-max-150x150.png"],[[191,82],"assets/images/resized/0010/6866/106866v1-max-250x250.png"],[[191,82],"assets/images/resized/0010/6866/106866v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/09/cardoz-ab-holds-second-close-of-sek124m.html","source_description":"Cardoz AB Holds Second Close of SEK124M Series A Financing","raised_amount":124000000,"raised_currency_code":"SEK","funded_year":2010,"funded_month":9,"funded_day":16,"company":{"name":"Cardoz","permalink":"cardoz","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.tmcnet.com/usubmit/2011/01/26/5267605.htm","source_description":"Nexstim, a Medical Device Company, Raises over EUR 11 Million in New Equity Financing","raised_amount":11000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":1,"funded_day":26,"company":{"name":"Nexstim","permalink":"nexstim","image":{"available_sizes":[[[150,40],"assets/images/resized/0011/9229/119229v1-max-150x150.jpg"],[[250,66],"assets/images/resized/0011/9229/119229v1-max-250x250.jpg"],[[269,72],"assets/images/resized/0011/9229/119229v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/06/ultragenyx-pharmaceutical-closes-45m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Ultragenyx Pharmaceutical Closes $45M Series A Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":20,"company":{"name":"Ultragenyx Pharmaceutical","permalink":"ultragenyx-pharmaceutical","image":{"available_sizes":[[[150,57],"assets/images/resized/0014/0132/140132v1-max-150x150.png"],[[210,80],"assets/images/resized/0014/0132/140132v1-max-250x250.png"],[[210,80],"assets/images/resized/0014/0132/140132v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/06/bonesupport-raises-sek120m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"BONESUPPORT Raises SEK120M","raised_amount":120000000,"raised_currency_code":"SEK","funded_year":2011,"funded_month":6,"funded_day":23,"company":{"name":"BONESUPPORT","permalink":"bonesupport","image":{"available_sizes":[[[150,54],"assets/images/resized/0008/4551/84551v1-max-150x150.jpg"],[[185,67],"assets/images/resized/0008/4551/84551v1-max-250x250.jpg"],[[185,67],"assets/images/resized/0008/4551/84551v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/07/spinevision-raises-5m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"SpineVision Raises $5M in Funding","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":6,"company":{"name":"SpineVision","permalink":"spinevision","image":{"available_sizes":[[[150,81],"assets/images/resized/0014/2838/142838v1-max-150x150.png"],[[178,97],"assets/images/resized/0014/2838/142838v1-max-250x250.png"],[[178,97],"assets/images/resized/0014/2838/142838v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/06/bonesupport-raises-sek70m-funding.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"BONESUPPORT Raises SEK70M in Funding","raised_amount":70000000,"raised_currency_code":"SEK","funded_year":2012,"funded_month":6,"funded_day":19,"company":{"name":"BONESUPPORT","permalink":"bonesupport","image":{"available_sizes":[[[150,54],"assets/images/resized/0008/4551/84551v1-max-150x150.jpg"],[[185,67],"assets/images/resized/0008/4551/84551v1-max-250x250.jpg"],[[185,67],"assets/images/resized/0008/4551/84551v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"HealthCap VI LP","funded_year":2011,"funded_month":4,"funded_day":11,"raised_amount":null,"raised_currency_code":"USD","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020110409e74b0002t&r=Rss&s=DJFVLS","source_description":"European Life Sciences Firm HealthCap Raising Sixth Fund"}],"video_embeds":[],"external_links":[]}